Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.
Front Immunol. 2023 Jun 7;14:1148317. doi: 10.3389/fimmu.2023.1148317. eCollection 2023.
Front Immunol. 2023.
PMID: 37350973
Free PMC article.
Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.
Rohila D, Park IH, Pham TV, Weitz J, Hurtado de Mendoza T, Madheswaran S, Ishfaq M, Beaman C, Tapia E, Sun S, Patel J, Tamayo P, Lowy AM, Joshi S.
Rohila D, et al.
Cancer Res. 2023 Aug 15;83(16):2675-2689. doi: 10.1158/0008-5472.CAN-22-3645.
Cancer Res. 2023.
PMID: 37306759
Free PMC article.
Item in Clipboard
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.
Joshi S, Sharabi A.
Joshi S, et al.
Pharmacol Ther. 2022 Jul;235:108114. doi: 10.1016/j.pharmthera.2022.108114. Epub 2022 Feb 2.
Pharmacol Ther. 2022.
PMID: 35122833
Free PMC article.
Review.
Item in Clipboard
Cite
Cite